Abstract
20-HETE is a biologically active product of arachidonic acid and cytochrome P450 ω-hydroxylase of the 4A gene family and is an abundant microsomal eicosanoid in the rat kidney.1 However, very little is known about factors controlling the biosynthesis and metabolic fate of 20-HETE in the kidney. Cyclooxygenase metabolizes 20-HETE into ω-OH-PGs, formation of which was proposed to explain the vasoconstrictor activity of 20-HETE in the kidney.2 Human platelets metabolize 20-HETE into a complex mixture of products of which 11,20-dihydroxyeicosatetraenoic acid (11,20-DiHETE), and 12,20-DiHETE are the major metabolites.3. We observed that the stimulation of the rat kidney with hormones or calcium ionophore results in an accumulation of 20-HETE, which is readily detectable by GC/MS.4, 5 The release of 20-HETE from renal slices stimulated by calcium ionophore cannot be inhibited with ETYA, which suggested to us that calcium influx is required for the release of 20-HETE. The isolated perfused kidney, challenged with angiotensin II (ang II) or endothelin-1, rapidly releases 20-HETE and often other CYP450 subterminal HETEs, into the perfusion fluid in amounts 5 to 10-fold higher relative to control levels. Brief stimulation of mTAL cells with ang II leads to a selective release of 20-HETE.6 These results suggested that 20-HETE could be released from renal tissue phospholipids via a receptor-mediated activation of phospholipase (PL)A2. In this study we obtained evidence that the release of 20-HETE from renal phospholipids is possible and represents a new component of ang II-dependent effects on renal function.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
M.H. Wang, D.E. Stec, M. Balazy, V. Mastyugin, C.S. Yang, R.J. Roman, and M.L. Schwartzman, Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2. Arch. Biochem. Biophys. 336: 240 (1996).
M.L. Schwartzman, J.R. Falck, P. Yadagiri, and B. Escalante, Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. J. Biol. Chem. 264: 11658 (1989).
E. Hill, F. Fitzpatrick, and R.C. Murphy, Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet. Br. J. Pharmacol. 106: 267 (1992).
B. Oyekan, M. Balazy, and J.C. McGiff, Renal oxygenases: differential contribution to vasoconstriction induced by endothelin-1 and angiotensin II. Am. J. Physiol., in press.
M.A. Carroll, M. Balazy, P. Margiotta, D.D. Huang, J.R. Falck and J.C. McGiff, Cytochrome P450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am. J. Physiol. 271: R863 (1996).
M. Lu, Y. Zhu, M. Balazy, K.M. Reddy, J.R. Falck, and W.H. Wang, Effect of angiotensin II on the apical K+ channel in the thick ascending limb of the rat kidney. J. Gen. Physiol. 108: 537 (1996).
S. Manna, J.R. Falck, N. Chacos, and J. Capdevila, Synthesis of arachidonic acid metabolites produced by purified kidney cortex microsomal cytochrome P-450. Tetrahedron Lett. 24: 33 (1983).
Y. Zhu, J.C. McGiff, and M. Balazy, Identification of 20-hydroxyeicosatetraenoic acid in rat kidney phospholipids. Proc. 43rd Conf. Am. Soc. Mass Spectrometry, 1148 (1995).
Y. Zhu, J.C. McGiff, and M. Balazy, Identification of arachidonate P-450 metabolites in human platelet phospholipids. Hypertension 25[part 2]: 854 (1995).
F. Snyder, Ether-linked lipids and their bioactive species: occurrence, chemistry, metabolism, regulation, and function, in: Biochemistry of Lipids, Lipoproteins and Membranes, D.E. Vance and J.E. Vance, eds., Elsevier, Amsterdam (1996).
K.K. Griendling, M.U. Fukai, B. Lassegue, and R.W. Alexander, Angiotensin II signaling in vascular smooth muscle-new concepts. Hypertension 29[part 2]: 366 (1997).
W.H. Wang, M. Lu, M. Balazy, and S.C. Hebert, Phospholipase A2 is involved in mediating the effect of extracellular Ca2+ on the apical K+ channels in the rat TAL. Am. J. Physiol. in press.
Y. Wen, M.C. Cabot, E. Clauser, S.L. Bursten, and J.L. Nadler, Lipid signal transduction pathways in angiotensin II type 1 receptor-transfected fibroblasts. Am. J. Physiol. 269: C435 (1995).
S. Takekoshi, Y. Kambayashi, H. Nagata, T. Takagi, Y. Yamamoto, and K. Watanabe, Activation of protein kinase C by oxidized diacylglycerols. Biochem. Biophys. Res. Commun. 217: 654 (1995).
Y. Cho, and V.A. Ziboh, 13-Hydroxyoctadecadienoic acid reverses epidermal hyperproliferation via selective inhibition of protein kinase Cβ activity. Biochem. Biophys. Res. Commun. 201: 257 (1994).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mao, K., Reddy, K.K., Falck, J.R., McGiff, J.C., Balazy, M. (1997). New Group of Lipid Mediators Containing ω-Hydroxyarachadonic Acid (20-HETE). In: Sinzinger, H., Samuelsson, B., Vane, J.R., Paoletti, R., Ramwell, P., Wong, P.YK. (eds) Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Advances in Experimental Medicine and Biology, vol 433. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1810-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1810-9_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1812-3
Online ISBN: 978-1-4899-1810-9
eBook Packages: Springer Book Archive